Jakub Stanek’s scientific contributions

Introduction Migraine, a prevalent neurological disorder, is characterized by recurrent episodes of moderate to severe headache, often accompanied by symptoms such as nausea, photophobia, and phonophobia. Triptans, which belong to the class of serotonin 5-HT1B/1D receptor agonists, are integral to the management of migraine, providing prompt relief from symptoms. Aim of the study To clarify how effective triptans are in treating migraines, highlighting their role in symptom relief and improving patients' quality of life Materials and methods The article is the result of a comprehensive analysis of present-day scientific literature, which has been collected from PubMed, Scopus, and Google Scholar. The literature was systematically reviewed utilizing specific keywords. Results Studies consistently show high efficacy of triptans in treating acute migraines. These pharmaceuticals markedly alleviate pain and symptoms like nausea, photophobia, and phonophobia, providing substantial pain relief. Differences in triptan medications' onset and half-life affect their therapeutic duration and headache recurrence rate. The pharmacokinetic properties of each triptan significantly affect its efficacy and headache recurrence likelihood. Frovatriptan, with its long half-life, showed superior efficacy in reducing migraine recurrence. Conversely, rizatriptan, with its rapid action, offered quick pain relief. In clinical trials, all triptans showed favorable tolerability profiles. Reported adverse effects were generally mild. Conclusions Triptans are effective and safe for managing acute migraines. The diverse formulations and swift onset make these treatments essential for migraine management. Choose a triptan based on efficacy, safety, and patient preferences. More research is needed to improve triptan treatments for migraine, focusing on reducing headache recurrence and enhancing patient tolerability.

Introduction and purpose of review: Statins are widely used drugs in the prevention of cardiovascular diseases, yet many patients experience side effects of statin use, mainly muscle symptoms, such as myopathy, which often lead to discontinuation of treatment. The aim of this literature review is to assess the role of the nocebo effect in reported muscle symptoms and its impact on statin discontinuation in patients with cardiovascular diseases. Methods: The review analysed the results of several studies, including key publications such as the N-of-1 trial by Wood et al.[1] and the work of Collins et al.[2] on the safety and efficacy of statin therapy. The review covered articles published between 2000 and 2023 that examined the impact of the nocebo effect on statin discontinuation[3-10]. Results: The collected data indicate that the nocebo effect plays a significant role in the reported muscle symptoms during statin use. The study by Wood et al.[1] showed no significant differences in reported symptoms between the groups taking statins, placebo, or receiving no treatment, suggesting that a substantial portion of the symptoms results from the nocebo effect. Similar findings were obtained in the study conducted by the StatinWISE group[4], where patients taking statins and placebo reported a comparable frequency of muscle symptoms. An analysis conducted by Collins et al.[2] indicates that the actual incidence of myopathy associated with statin therapy is much lower than commonly reported. Conclusions: The nocebo effect significantly influences the perceived adverse effects of statins, which may lead to the unjustified discontinuation of these drugs by patients with cardiovascular diseases. Further research is needed to better understand the psychological mechanisms affecting statin tolerance and to develop educational and clinical strategies aimed at minimizing the nocebo effect and improving long-term adherence to therapy.

Introduction: The success in preventing and treating Rh D alloimmunization is a major accomplishment in modern obstetrics. The widespread use of Rh D immune globulin has led to a decline in red cell alloimmunization. Despite evidence of its effectiveness, many cases of Rh D alloimmunization persist due to non-compliance with established protocols. Implementing routine anti-D prophylaxis (RAADP) during the third trimester is well-established but requires more careful. Aim of study: The aim of the study is to summarize the available knowledge about alloimmunization in pregnancy and methods of prophylaxis. The definition, patomechanism, methods of treatment and prophylaxis were summarized and described. Materials and methods: The literature available in PubMed database was reviewed using following keywords: “alloimmunization in pregnancy”, “serological conflict”, “fetal anemia”, “HDFN”, “prophylaxis of alloimmunization”. Conclusion: Advancements in diagnosing, treating, and preventing hemolytic disease of the fetus and newborn are notable. Quick, non-invasive diagnostics have facilitated more efficient treatment implementation. Prevention methods include specific and nonspecific prophylaxis, which can start during or after pregnancy. Numerous guidelines and studies exist regarding immunoglobulin use in pregnancy. However, medical staff education on managing hemolytic disease during pregnancy is crucial.

Introduction and purpose Hyperhidrosis (HH) is a medical conditions that affects more and more people every year. It is characterized by undue sweating without any temperature changes and significantly above the body’s thermoregulation needs. Primary hyperhidrosis is associated with genetic and psychological factors, as the etiology is not yet found. Treatment is aimed at the symptoms. Secondary hyperhidrosis happens as an adverse event of drugs taken by patient or is a part of neurological, endocrine or oncological diseases. Teratment should be focused on the main underlying disease. The quality of life of these patients is reduced and it affects their psychological health.This study inevstigates currently available methods of treatment. State of knowledge Various treatment options for hyperhidrosis range from topical aluminum salts for mild cases to oral anti-cholinergic agents for more severe conditions. Additional methods include iontophoresis, lasers like Nd:Yag, and botulinum toxin injections, known for their effectiveness. Surgical procedures such as Endoscopic Thoracic Sympathectomy, local skin excision, liposuction-curettage are also available for severe cases. Consultation with a healthcare provider is crucial to determine the most suitable treatment based on individual needs and preferences. Conclusions Literature provides valuable insights into hyperhidrosis and its treatments, emphasizing the importance of patient expectations and safety. Starting with topical aluminum salts for mild cases, treatments need to be reapplied regularly. Surgical options are considered if conservative treatments fail, but they come with potential risks. Botulinum toxin injections stand out for their efficacy, quick procedure, and the convenience of one or two annual sessions, making them a popular choice in many aesthetic clinics. Consulting with healthcare professionals is key to selecting the most suitable treatment approach for individual needs.

Treating acne vulgaris remains a significant challenge for dermatologists. Dermocosmetics are becoming an essential component of acne management. The active ingredients in dermocosmetics help support dermatological treatments, while gentle formulations help maintain the skin's lipid barrier, reduce transepidermal water loss, and minimize the risk of irritation. Our objective was to review the active ingredients and various preparations used in dermocosmetics for acne, and to emphasize the clinical evidence supporting their effectiveness.

Introduction and Purpose: Intermittent fasting (IF) has become a popular strategy for combating obesity and improving metabolic health. This dietary regimen alternates between periods of fasting and eating, aiming to enhance cellular health and increase longevity. With obesity rates doubling globally since 1990 and metabolic diseases on the rise, IF offers a potential solution by promoting metabolic benefits and reducing obesity-related conditions. Material and Method: This review examines various IF methods, including alternate-day fasting, the 5:2 diet, and time-restricted eating. The analysis focuses on the impact of these fasting methods on body weight, insulin sensitivity, and lipid profiles, based on a compilation of studies that explore the physiological effects and health outcomes associated with IF. Results: IF has shown to be effective in reducing body weight and improving metabolic parameters. Studies indicate significant benefits in insulin sensitivity and lipid profiles, with some variations across different IF protocols. Physiological insights reveal that IF leads to a metabolic switch from glucose-based to ketone-based energy, which plays a critical role in its effectiveness. Conclusions: Intermittent fasting appears to be a viable alternative to continuous calorie restriction for weight loss and metabolic enhancement. It not only aids in weight management but also offers additional health benefits such as improved insulin sensitivity and better lipid profiles. However, more long-term studies are needed to fully understand its benefits and potential risks. Future research should focus on optimizing fasting protocols and exploring their long-term effects on health and disease.

Introduction and Aim of the Study: Apple cider vinegar (ACV) has been used for centuries in various cultural and medical contexts globally. This study seeks to explore ACV's traditional and contemporary applications, evaluating scientific evidence for its efficacy and safety. Material and Methods: This review synthesizes information from PubMed, Google Scholar, and other scientific sources. Key search terms included "apple cider vinegar," "apple cider vinegar medical use," "apple cider vinegar antimicrobial effect," "apple cider vinegar lipid profile," "apple cider vinegar glucose level," "apple cider vinegar preparation," and "apple cider vinegar historical use." Results: Research supports ACV's traditional role as a disinfectant, demonstrating effectiveness against a range of bacteria and fungi. Both animal and human studies suggest ACV may help lower cholesterol and triglyceride levels while boosting HDL cholesterol. Evidence indicates ACV can enhance insulin sensitivity and reduce blood glucose levels, offering benefits for type 2 diabetes management. ACV shows antioxidant properties, potential for lowering blood pressure, and use in certain skin diseases, though further research is needed to confirm these effects. Conclusions: The historical use of ACV in traditional medicine finds partial support in modern scientific research. Its antimicrobial, lipid-modulating, and glucose-regulating properties are documented, suggesting potential benefits for cardiovascular health, weight management, and metabolic regulation. Nonetheless, the evidence for its cosmetic applications and impact on muscle cramps remains less definitive. Additional research involving larger, diverse populations is necessary to fully validate ACV's benefits and establish safe usage guidelines.

Introduction and purpose of review: The term glycemic index (GI) is the measure of how much a specific substance increases the postprandial blood glucose level [1]. Substances with lower GI promote a lower glycemic response and are said to promote satiety, postprandial insulin secretion and maintain insulin sensitivity and therefore help to control blood glucose concentrations [2]. According to guidelines on the management of patients with diabetes, type 2 diabetes mellitus patients’ source of carbohydrates in diet should be whole grain cereal products especially with low GI [3]. Type 2 diabetes is a chronic, metabolic disease occurring mostly in adults. It leads to numerous chronic complications that include e.g. macroangiopathy, retinopathy, nephropathy, neuropathy and diabetic foot as well as vulnerability to infections [2]. These complications lower the quality of life, generate costs when treating them and eventually lead to death. Currently there are about 422 million people with diabetes worldwide and the number is expected to rise [3]. Therefore it is crucial for patients to maintain their blood glucose at stable levels to prevent progression of the disease and its complications. The glycemic response can be modified by implementing a low GI diet. The aim of this study is to provide an overview of selected strategies lowering the glycemic index and the probable mechanisms by which they work. Methods: For this review, articles in the Pubmed and Google Scholar databases were analyzed as well as the references of previously found articles. Current state of knowledge: Existing studies show that some strategies alter the glycemic index and glycemic response that can help diabetic patients to better control their glucose blood level. Summary: This review summarizes studies concerning methods of lowering the glycemic index and mechanisms of action of those specific methods.

Introduction and objective: Micrographic Mohs surgery, a highly precise surgical technique, has long been regarded as a cornerstone in dermatology for the treatment of various skin cancers. This review aims to comprehensively summarize the current understanding of the principles and clinical applications of Mohs surgery, with a specific focus on providing insights to clinicians and researchers. State of Knowledge: Mohs surgery is particularly renowned for its unparalleled efficacy in treating basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and other skin malignancies, especially in anatomically challenging areas. The technique involves meticulous removal of cancerous tissue layers while sparing healthy surrounding tissue, facilitated by microscopic examination of surgical margins. Recent advancements in Mohs surgery have led to improved outcomes, with techniques such as immunostaining enhancing the accuracy of tumor detection and minimizing the need for additional surgeries. Materials and methods: This review of studies is based on scientific articles avaible in PubMed, Google Scholar databases and Elsevier. Summary: Micrographic Mohs surgery remains a cornerstone of dermatologic oncology, offering unparalleled precision and cure rates for various skin cancers. Its success lies in its ability to achieve complete tumor removal while preserving maximal tissue integrity and cosmesis. Future research endeavors should focus on refining surgical techniques, optimizing patient selection criteria, and exploring adjunctive therapies to further improve outcomes and patient satisfaction. By advancing our understanding and application of Mohs surgery, we can continue to provide optimal care for patients with skin cancer, ultimately improving their quality of life and prognosis.